Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05370807
Title A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma (RegoMel)
Acronym RegoMel
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universitair Ziekenhuis Brussel
Indications
Therapies
Age Groups: adult | senior
Covered Countries BEL


No variant requirements are available.